Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh

Frontiers in Public Health

Public Health

Ibrahim F. Halawani¹  Fuad M. Alzahrani¹  Khalid J. Alzahrani¹  Nazmul Sharif²  Nadim Sharif³  Anowar Khasru Parvez³  Shuvra Kanti Dey³  Afsana Khan⁴  Angel Gabriel Kuc Castilla⁵  Debora Libertad Ramírez Vargas⁶  Isabel De la Torre Díez⁷ 

[1] Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia;Department of Mathematics, Rajshahi University of Engineering & Technology, Rajshahi, Bangladesh;Department of Microbiology, Jahangirnagar University, Savar, Bangladesh;Department of Statistics, Jahangirnagar University, Savar, Bangladesh;Universidad Internacional Iberoamericana, Campeche, Mexico;Universidad Europea del Atlántico, Santander, Spain;Universidad Internacional Iberoamericana, Arecibo, PR, United States;Universidad Internacional Iberoamericana, Campeche, Mexico;Universidade Internacional do Cuanza, Kuito, Angola;Fundación Universitaria Internacional de Colombia, Bogotá, Colombia;University of Valladolid, Valladolid, Spain;

关键词: long-COVID-19;    comorbidity;    diabetes;    cardiovascular disease;    Bangladesh;   

DOI  :  10.3389/fpubh.2023.1222868

 received in 2023-05-15, accepted in 2023-10-09,  发布年份 2023

来源: Frontiers

【 摘 要 】

IntroductionCo-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh.MethodsWe collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival.ResultsCOVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79–4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients.DiscussionRisk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh.

【 授权许可】

Unknown   
Copyright © 2023 Sharif, Sharif, Khan, Halawani, Alzahrani, Alzahrani, Díez, Vargas, Castilla, Parvez and Dey.